Inhibitors of human histone deacetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates

scientific article published in February 2002

Inhibitors of human histone deacetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1021/JM015568C
P698PubMed publication ID11831887

P2093author name stringPeter Atadja
Manfred Jung
Kenneth W Bair
Lidia C Sambucetti
Wendy D Cornell
Michael A Green
Paul Kwon
Heather Walker
Kobporn Lulu Howell
Nancy Trogani
Stacy W Remiszewski
P433issue4
P407language of work or nameEnglishQ1860
P921main subject4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamideQ27216175
P304page(s)753-757
P577publication date2002-02-01
P1433published inJournal of Medicinal ChemistryQ900316
P1476titleInhibitors of human histone deacetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates
P478volume45

Reverse relations

cites work (P2860)
Q40627110A novel series of histone deacetylase inhibitors incorporating hetero aromatic ring systems as connection units
Q44581055Ab initio study of the binding of Trichostatin A (TSA) in the active site of histone deacetylase like protein (HDLP).
Q44442892Amide analogues of TSA: synthesis, binding mode analysis and HDAC inhibition
Q58860105Computer- and Structure-Based Lead Identification for Epigenetic Targets
Q28550025Exploration of Novel Inhibitors for Class I Histone Deacetylase Isoforms by QSAR Modeling and Molecular Dynamics Simulation Assays
Q24646019Function-oriented biosynthesis of beta-lactone proteasome inhibitors in Salinispora tropica
Q33808222Gymnochromes E and F, cytotoxic phenanthroperylenequinones from a deep-water crinoid, Holopus rangii
Q55952250Histone Deacetylase Inhibitors
Q37125200Histone deacetylase inhibitors: a novel class of anti-cancer agents on its way to the market
Q24535587Histone deacetylases (HDACs): characterization of the classical HDAC family
Q34743301Histone-deacetylase inhibitors: novel drugs for the treatment of cancer
Q45232745Homology modeling, force field design, and free energy simulation studies to optimize the activities of histone deacetylase inhibitors
Q24633204Improved total synthesis of the potent HDAC inhibitor FK228 (FR-901228)
Q36931722In vitro plasma stability, permeability and solubility of mercaptoacetamide histone deacetylase inhibitors
Q40647510Indole amide hydroxamic acids as potent inhibitors of histone deacetylases
Q33598588Induction of human gamma globin gene expression by histone deacetylase inhibitors
Q99237825Natural Products Impacting DNA Methyltransferases and Histone Deacetylases
Q38315538Natural products as zinc-dependent histone deacetylase inhibitors
Q37011621Pharmacokinetics-pharmacodynamics and antitumor activity of mercaptoacetamide-based histone deacetylase inhibitors
Q58036611Probing the structure-activity relationship of endogenous histone deacetylase complexes with immobilized peptide-inhibitors
Q44434335Psammaplins from the Sponge Pseudoceratina purpurea: Inhibition of Both Histone Deacetylase and DNA Methyltransferase
Q39203797Quinazoline-2,4(1H, 3H)-diones inhibit the growth of multiple human tumor cell lines
Q33556502Radionuclide labeling and evaluation of candidate radioligands for PET imaging of histone deacetylase in the brain
Q35563857Recent progress in the development of assays suited for histone deacetylase inhibitor screening
Q46340055Screening of amide analogues of Trichostatin A in cultures of primary rat hepatocytes: search for potent and safe HDAC inhibitors
Q41487113SelSA, selenium analogs of SAHA as potent histone deacetylase inhibitors
Q36512713Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells
Q37383739Synthesis and HDAC inhibitory activity of isosteric thiazoline-oxazole largazole analogs
Q28830285The marine bromotyrosine derivatives
Q42443365Trichostatin A and structurally related histone deacetylase inhibitors induce 5-lipoxygenase promoter activity